KYNTRA BIO, INC. - 8-K Filing
Kyntra Bio held its annual stockholder meeting on June 12, 2026, where Michael Kauffman was elected as a Class III director with 96.04% of the votes cast (1,239,169 for), and shareholders approved executive compensation (1,242,005 for) and ratified PwC as auditors (2,712,825 for). (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $FGEN